MENLO PARK, Calif., May 06, 2023 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (SGHT) (Nasdaq: SGHT), an eyecare technology company focused on developing and commercializing innovative technology that ...

MENLO PARK, Calif., May 06, 2023 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on developing and commercializing innovative technology that enables ...

NEW YORK — Trabectome surgery is a reasonable approach in patients with mild glaucoma, a speaker said here. "We would recommend it for patients with high preoperative IOP or a target IOP of more than ...

Please provide your email address to receive an email when new articles are posted on . Significantly more patients with multifocal IOLs were spectacle-free for near ...

MENLO PARK, Calif., May 28, 2024 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) ("Sight Sciences" or the "Company"), an eyecare technology company focused on developing and commercializing ...

Microinvasive glaucoma surgery (MIGS) has revolutionized the options available to patients with mild to moderate glaucoma. Most MIGS procedures are performed in conjunction with cataract extraction ...

The CDC reports that over three million Americans have glaucoma. The number may reach 6.3 million by 2050 as the aging population grows. Glaucoma is affecting so many lives, so it’s important to know ...

Bathers at Asnières (1884) by Georges Seurat (as seen by someone with mild glaucoma).